Product Images Sildenafil
View Photos of Packaging, Labels & Appearance
- Figure 1: Kaplan-Meier Plot of Mortality by Sildenafil Dose - sildenafil fig1
- Figure 2. Effects of Other Drugs on Sildenafil Pharmacokinetics - sildenafil fig2
- Figure 3. Effects of Sildenafil on Other Drugs - sildenafil fig3
- Figure 4. Change from Baseline in 6-Minute Walk Distance (meters) at Weeks 4, 8, and 12 in Study 1: Mean (95% Confidence Interval) - sildenafil fig4
- Figure 5. Placebo-Corrected Change From Baseline in 6-Minute Walk Distance (meters) at Week 12 by study subpopulation in study 1: Mean (95% Confidence Interval) - sildenafil fig5
- Figure 6. Kaplan-Meier Plot of Time (in Days) to Clinical Worsening of PAH in Study 2 - sildenafil fig6
- Figure 7. Mean Change from Baseline in Six Minute Walk (meters) by Visit to Week 12 – ITT Population Sildenafil Protocol A1481244 - sildenafil fig7
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg per 12.5 mL - Container Label - sildenafil fig8
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg per 12.5 mL - Container-Carton (1 Vial) - sildenafil fig9
- Sildenafil Citrate Chemical Structure - sildenafil str
Product Label Images
The following 10 images provide visual information about the product associated with Sildenafil NDC 55150-166 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 4. Change from Baseline in 6-Minute Walk Distance (meters) at Weeks 4, 8, and 12 in Study 1: Mean (95% Confidence Interval) - sildenafil fig4

Not available. The text appears to be a jumbled combination of characters and words with no coherent meaning.*
Figure 5. Placebo-Corrected Change From Baseline in 6-Minute Walk Distance (meters) at Week 12 by study subpopulation in study 1: Mean (95% Confidence Interval) - sildenafil fig5

Figure 6. Kaplan-Meier Plot of Time (in Days) to Clinical Worsening of PAH in Study 2 - sildenafil fig6

Figure 7. Mean Change from Baseline in Six Minute Walk (meters) by Visit to Week 12 – ITT Population Sildenafil Protocol A1481244 - sildenafil fig7

The text describes a plot that shows the mean change from baseline (in meters) with the standard error for each treatment and visit up to week 12. It also includes some random characters and possibly missing information.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg per 12.5 mL - Container Label - sildenafil fig8

This is a description of a medication called Sildenafil Injection. It comes in a sterile single-dose vial containing 10mg per 12.5mL of solution. It is intended for intravenous use and the unused portion is to be discarded. Each mL of solution has 1.124mg of sildenafil citrate USP equivalent to 0.8mg sildenafil and 50.5mg dextrose and Water for Injection. The vial stopper is made without natural rubber latex. Recommended usual dosage is included in the prescription information that accompanies the medication. It is distributed by AuroMedics Pharma LLC in Windsor, NJ, and is made in India. It must be stored between 68" to 77°F.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg per 12.5 mL - Container-Carton (1 Vial) - sildenafil fig9

This is a drug information sheet for Sildenafil Injection, manufactured by AuroMedics Pharma LLC. It is an intravenous medication that comes in a 12.5 mL single-dose vial, with 10mg of Sildenafil per mL. The medication is used for erectile dysfunction and high blood pressure in the lungs. The typical dosage is not provided and should follow the prescribing information. The packaging and storage recommendations are also provided. Overall, it is an informational document for medical professionals.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.